Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,859,516
  • Shares Outstanding, K 612,900
  • Annual Sales, $ 20,101 M
  • Annual Income, $ 1,447 M
  • 36-Month Beta 0.62
  • Price/Sales 1.54
  • Price/Cash Flow 14.08
  • Price/Book 2.30

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.79 +1.35%
on 05/03/18
52.10 -3.15%
on 05/17/18
+0.94 (+1.90%)
since 04/25/18
3-Month
49.03 +2.92%
on 04/25/18
54.81 -7.94%
on 02/26/18
-4.11 (-7.53%)
since 02/23/18
52-Week
44.88 +12.43%
on 08/10/17
57.94 -12.91%
on 01/31/18
+4.09 (+8.82%)
since 05/25/17

Most Recent Stories

More News
Here's Why You Should Sell Fresenius Medical (FMS) Stock Now

A rapidly changing healthcare environment in the United States, sluggish Q1 and competition in the niche markets are major headwinds for Fresenius Medical (FMS).

GHDX : 38.52 (+0.36%)
ABMD : 394.28 (-0.05%)
EXEL : 20.84 (+1.66%)
FMS : 50.46 (+0.22%)
Fresenius Medical (FMS) Misses on Q1 Earnings, Lowers View

Lackluster performance in North America and foreign exchange headwinds mar Fresenius Medical's (FMS) bottom line in Q1.

VAR : 118.54 (-0.27%)
BAX : 72.53 (+0.17%)
ISRG : 456.56 (-0.27%)
FMS : 50.46 (+0.22%)
3 Reasons Why You Should Invest in Baxter International Now

Baxter (BAX) gains ground on strategic buyouts and a raised guidance for 2018.

BAX : 72.53 (+0.17%)
BIO : 287.93 (-0.39%)
EVHC : 43.57 (+0.83%)
FMS : 50.46 (+0.22%)
The Zacks Analyst Blog Highlights: ArcelorMittal, Fresenius Medical Care AG, Orion Engineered Carbons S.A., Royal Dutch Shell and Globant S.A.

The Zacks Analyst Blog Highlights: ArcelorMittal, Fresenius Medical Care AG, Orion Engineered Carbons S.A., Royal Dutch Shell and Globant S.A.

RDS.A : 68.17 (-2.22%)
MT : 33.05 (-1.34%)
GLOB : 51.15 (+0.87%)
OEC : 27.80 (-0.89%)
FMS : 50.46 (+0.22%)
ECB Sticks to Accommodative Monetary Stance: 5 Top Picks

The ECB kept its main refinancing rate, and rates on marginal lending facility and deposit facility at unchanged at 0%, 0.258% and -0.4%, respectively.

RDS.A : 68.17 (-2.22%)
MT : 33.05 (-1.34%)
GLOB : 51.15 (+0.87%)
OEC : 27.80 (-0.89%)
FMS : 50.46 (+0.22%)
IMF Raises Its Growth Forecast for Germany: 4 Top Picks

IMF's recent forecast on Germany's economic growth and encouraging comments from the country's finance ministry indicate its resilience to the recent economic cooldown.

VLKAY : 39.0100 (-0.48%)
LEGIF : 108.3148 (+0.35%)
FMS : 50.46 (+0.22%)
DB : 12.05 (-1.63%)
Global Growth to Hit 7-Year High, Says IMF: 5 Picks

Projections for growth in the United States, Britain and Eurozone have experienced an upward revision.

PUK : 50.38 (+0.02%)
MT : 33.05 (-1.34%)
MU : 61.35 (-0.23%)
FMS : 50.46 (+0.22%)
M : 34.13 (+0.29%)
Here's Why You Should Invest in Fresenius Medical Right Now

Fresenius Medical (FMS) receives a boost from solid guidance, higher geographical revenues and strategic acquisitions.

BHVN : 34.50 (-0.12%)
BIO : 287.93 (-0.39%)
EVHC : 43.57 (+0.83%)
FMS : 50.46 (+0.22%)
3 Reasons Why You Should Invest in Fresenius Medical Now

Wide range of dialysis products, deliberate initiatives to gain market traction and solid international foothold are major catalysts for Fresenius Medical (FMS) at the moment.

ATHN : 153.19 (-0.17%)
BIO : 287.93 (-0.39%)
FMS : 50.46 (+0.22%)
PKI : 74.32 (-1.72%)
The Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and Olympus

The Zacks Analyst Blog Highlights: Cerner, AmerisourceBergen, Fresenius and Olympus

CERN : 59.94 (+0.84%)
ABC : 85.49 (+1.66%)
FMS : 50.46 (+0.22%)
OCPNY : 35.1100 (+1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade FMS with:

Business Summary

Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture...

See More

Key Turning Points

2nd Resistance Point 50.83
1st Resistance Point 50.64
Last Price 50.46
1st Support Level 50.28
2nd Support Level 50.11

See More

52-Week High 57.94
Fibonacci 61.8% 52.95
Fibonacci 50% 51.41
Last Price 50.46
Fibonacci 38.2% 49.87
52-Week Low 44.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar